renal cell carcinoma

Videos

Patterns and Predictors of Oral Anticancer Agent Use for Metastatic RCC

03/18/2021

Journal of Clinical Pathways

Videos

Real-World Treatment Sequences After First-Line Therapy in Metastatic RCC

03/18/2021

Journal of Clinical Pathways

Research in Review

Removing Metastases Improves Survival for Patients With Kidney Cancer

04/28/2017

JCP Editors

Patients with renal cell carcinoma who have surgery to remove metastatic tumors are likely to double their life expectancy, according to research published in The Journal of Urology (April...

...

04/28/2017

Journal of Clinical Pathways

Department

Pazopanib More Cost-Effective Than Sunitinib for Patients With Renal Cell Carcinoma

04/12/2017

JCP Editors

Medicare patients with advanced renal cell carcinoma benefit from lower costs and hospital admissions if treated with pazopanib (Votrient, Novartis) rather than sunitinib (Sutent, Pfizer). Advanced renal cell...

...

04/12/2017

Journal of Clinical Pathways

Research in Review

Pazopanib Cost-Effective for Patients With Renal Cell Carcinoma

03/28/2017

JCP Editors

Medicare patients with advanced renal cell carcinoma benefit from lower costs and hospital admissions if treated with pazopanib rather than sunitinib, according to research presented at the AMCP Managed Care &...

...

03/28/2017

Journal of Clinical Pathways

Research in Review

Kidney Cancer Pulmonary Metastases May Hide Primary Lung Cancer Diagnosis

03/27/2017

JCP Editors

Primary non-small cell lung cancer (NSCLC) may be underdiagnosed in patients with metastatic renal cell carcinoma, according to new research. ----- Related Content Leptomeningeal Metastases More Common in EGFR+...

...

03/27/2017

Journal of Clinical Pathways